Thanks for bringing up this point. I agree when viewed this way, the compensation seems on the higher side but this is at the moment only an enabling resolution. We need to wait and see how much they actually take and what are the revenues at that point of time. Sakar’s promoter remuneration has been within normal range until now though it has increased rapidly in recent years. I view it as a negative but not a show stopper as yet. If the revenues increase in line with the salary, it would be okay I guess. But yes, this is a point that needs to be watched.
3 Likes
Hello guys,
i had two questions -
-
As per the AR 2024 cash flow statement they received ~Rs 115 crs via increase in provision and there was a tax cash outflow of Rs ~117 crs - can anyone clarify on this transaction as there is nothing in balance sheet provisions and notes - Attaching screenshot below for reference -
-
I was checking Sakar healthcare’s export data on Volza - as per company’s AR 2024 - they exported goods worth Rs 94 crs - but as per the volza portal the exports were to the tune of ~$ 187 mn which translates to ~Rs 1500 crs - there were six sakar healthcares with same address - couldnt find anyother company online which could also be named Sakar Healthcare and all these shipments source country was India - Anyone has any idea what is it that i am doing wrong here - Attaching screen shots of volza below for reference -
Thank You
1 Like
Hi, On point no. 1, this is an error. There is some typo or something, I have got it confirmed from the company. While this is an error, the company has confirmed that the final figure of Net Cash Inflow is correct due to the offsetting impact of Increase / (decrease) in Provisions and Direct Taxes.
1 Like
Here is a link to the presentation at the event organised by Arihant Capital
1 Like
